Home › Stocks › APVO › Changes
Who bought & sold APVO (Q2 2026)
Funds holding (Q2 2026)10
New positions2
Added1
Reduced2
Exited1
As of Q2 2026, 10 institutional funds reported holding APVO (APTEVO THERAPEUTICS INC): 2 opened new positions, 1 added, 2 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (2)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC New | 10.82K | $48.04K | — |
| BARCLAYS PLC New | 31 | $138 | — |
Added to positions (1)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 21.54K | $96.00K | 0.0 | +1.90K sh (+9.7%) |
Reduced positions (2)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| UBS Group AG | 730 | $3.24K | — | -2.71K sh (-78.8%) |
| Geode Capital Management | 10.82K | $48.04K | — | -2.52K sh (-18.9%) |
Exited positions (1)
Held in the prior quarter but not reported in the latest filing.
| Fund | Shares | Value | Weight |
|---|---|---|---|
| CWM, LLC Exited | 5 | $21 | — |